title: [Combined hormone therapy in hyperplasia of the endometrium].
abstract: The combined hyperplastical endometrial processes are very common pathology. In spite of noticeable achievements in hormonotherapy to treat the above trouble the recurrence rate comes up to as high as 45%. The recurrent combined hyperplastical endometrial processes prophylaxis with making use of the intrauterine system with levonorgestrel "Mirena" has been shown to be effective, with the above-mentioned system having been inserted on completion of the 6-month course of treatment with orgametryl.
authors.forename: V V
authors.initials: VV
authors.lastname: Bespoiasnaia
authors.forename: K P
authors.initials: KP
authors.lastname: Tumasian
authors.forename: I V
authors.initials: IV
authors.lastname: Voronovskaia
mesh_terms: D000328:Adult; D004359:Drug Therapy, Combination; D004714:Endometrial Hyperplasia / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D006801:Humans; D007436:Intrauterine Devices, Medicated; D016912:Levonorgestrel / Q000627:therapeutic use*; D008875:Middle Aged; D045167:Progesterone Congeners / Q000627:therapeutic use*; D012008:Recurrence; D014599:Uterus
chemical_list: D045167:Progesterone Congeners; D016912:Levonorgestrel